Republicans, on the other hand, were twice as likely to trust Trump (84%), Kennedy (81%), and Mehmet Oz (83%) — who is Trump’s nominee to lead the Center for Medicaid and Medicare Services. Less than 20% of Democrats trusted these individuals.
US berry-related outbreaks of intestinal viruses such as hepatitis A and norovirus have been linked to imported rather than domestic fresh and frozen berries.
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the Senate Committee on Health, Education, Labor and Pensions.
Caroline Kennedy urged senators to reject her cousin, Robert F. Kennedy Jr., as President Donald Trump’s nomination to lead the U.S. Department of Health and Human Services, calling him a “predator.”
Sixty-seven active TB cases and 79 latent TB cases have been reported in 2 Kansas counties since the beginning of 2024.
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral
As research continues, those involved say this would be a game changer, especially for patients with very limited options.
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.
Doctors are issuing urgent warnings about a common antibiotic after Emmie Bellucci, 12, of Texas fell mysteriously ill last year with respiratory failure shortly after taking her second course of it.
Liberty-based Vitti Labs, a human tissue bank, is suing the Food and Drug Administration over how the agency is regulating a product derived from umbilical cords. Vitti filed a lawsuit against the FDA on Jan. 7, challenging how it classifies a Vitti Labs product called Cordgraft.